← All funded startups

June 12, 2026

KalVista

KalVista is a developer of oral protease inhibitor drugs for rare diseases.

Round: —
Amount raised: $1.9B
Lead investor: —
Industry: —
Headquarters: Framingham, United States
Employees: —
Website: —
LinkedIn: —

Source: Axios Pro Rata